WallStreetZenWallStreetZen

NASDAQ: IRWD
Ironwood Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ironwood Pharmaceuticals revenue was $338.99M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $122.1M, up 43.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRWD annual revenue was $351.4M, with -20.6% growth year-over-year.

IRWD past revenue growth

How has IRWD's revenue growth performed historically?

Company
-10.42%
Industry
2.44%
Market
20.74%
IRWD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IRWD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IRWD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IRWD revenue history

Current Revenue
$339.0M
Current Earnings
$28.5M
Current Profit Margin
8.4%

Be the first to know when IRWD announces revenue.

IRWD Revenue History By Year

IRWD Yearly RevenueIRWD RevenueIRWD ChangeIRWD Revenue Growth
2024-12-31$351.41M-$91.33M-20.63%
2023-12-31$442.74M$32.14M+7.83%
2022-12-31$410.60M-$3.16M-0.76%
2021-12-31$413.75M$24.23M+6.22%
2020-12-31$389.52M-$38.89M-9.08%
2019-12-31$428.41M$81.77M+23.59%
2018-12-31$346.64M$48.36M+16.21%
2017-12-31$298.28M$24.32M+8.88%
2016-12-31$273.96M$124.40M+83.18%
2015-12-31$149.56M$73.12M+95.66%
2014-12-31$76.44M$53.56M+234.06%
2013-12-31$22.88M-$127.36M-84.77%
2012-12-31$150.25M$84.37M+128.09%
2011-12-31$65.87M$22.01M+50.19%
2010-12-31$43.86M$9.54M+27.78%
2009-12-31$34.32M$15.94M+86.70%
2008-12-31$18.38M$7.92M+75.68%
2007-12-31$10.46M$7.32M+233.25%
2006-12-31$3.14MN/AN/A

1 of 2

Ironwood Pharmaceuticals Revenue FAQ

What was IRWD's revenue last quarter?

On Invalid Date, Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q3 2025 revenue of $122.06 million up 33.26% year over year. In the same quarter last year, Ironwood Pharmaceuticals's revenue was $91.59 million.

What was Ironwood Pharmaceuticals's revenue in 2024?

Ironwood Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $351.41 million, a 20.63% decrease year over year.

How much does Ironwood Pharmaceuticals make in a day?

Based on Ironwood Pharmaceuticals annual revenue for the past five years, IRWD makes an average of $1,100,283.29 per day.

What was Ironwood Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2025, Ironwood Pharmaceuticals's revenue has grown -10.42% year over year. This is 12.86 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 2.44%. Ironwood Pharmaceuticals's revenue in the past year totaled $338.99 million.

How much does Ironwood Pharmaceuticals make in a year?

Ironwood Pharmaceuticals's revenue by year for the past five years is:
  • Ironwood Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $351.41 million, a 20.63% decrease year over year.
  • Ironwood Pharmaceuticals's annual revenue for Dec 31, 2023 was $442.74 million, a 7.83% increase from 2022.
  • Ironwood Pharmaceuticals's annual revenue for 2022 was $410.60 million, a 0.76% decrease from 2021.
  • Ironwood Pharmaceuticals's annual revenue for 2021 was $413.75 million, a 6.22% increase from 2020.
  • Ironwood Pharmaceuticals's annual revenue for 2020 was $389.52 million, a 9.08% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.